4.7 Editorial Material

Effects of percutaneous estradiol-oral progesterone versus oral conjugated equine estrogens-medroxyprogesterone acetate on breast cell proliferation and bcl-2 protein in healthy women

Journal

FERTILITY AND STERILITY
Volume 95, Issue 3, Pages 1188-1191

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.fertnstert.2010.09.062

Keywords

Percutaneous estradiol; micronized progesterone; HT; proliferation; bcl-2 protein; normal breast tissue

Ask authors/readers for more resources

In a prospective, randomized clinical study 77 women were assigned randomly to receive sequential hormone therapy with either conventional oral conjugated equine estrogens (0.625 mg) with the addition on 14 of the 28 days of oral medroxyprogesterone acetate (5 mg) or natural E-2 gel (1.5 mg) with oral micronized P (200 mg) on 14 of the 28 days of each cycle. Because oral conjugated equine estrogens-medroxyprogesterone acetate induced a highly significant increase in breast cell proliferation in contrast to percutaneous E-2-oral P with a difference between therapies approaching significance, the former therapy has a marked impact on the breast whereas natural percutaneous E-2-oral micronized P has not. (Fertil Steril (R) 2011;95:1188-91. (C) 2011 by American Society for Reproductive Medicine.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available